New ZEISS iCeMS Innovation Core collaborative laboratory opened Topics Press Release About ZEISS Press Photos Further Articles Jena/Germany, Kyoto/Japan | 30 October 2019 | ZEISS Research Microscopy Solutions ZEISS and Kyoto University are intensifying their cooperation and have signed a new strategic research agreement. As part of the agreement, the partners are opening the ZEISS iCeMS... Read more
Roche announced today that the European Medicines Agency (EMA) has validated the company’s Marketing Authorisation Application (MAA) for satralizumab for the treatment of adult and adolescent patients with neuromyelitis optica spectrum disorder (NMOSD), granting it Accelerated Assessment. Validation confirms that the submission is complete and signifies the MAA is under review by the EMA’s Committee... Read more
Thermo Fisher Scientific Launches Cell Culture Media as First to Remain Stable When Stored at Room Temperature Storing at room temperature offers labs greater flexibility and requires less energy CARLSBAD, Calif., Oct. 21, 2019 /PRNewswire/ — For biological researchers looking to reduce their reliance on cold storage without disrupting their existing workflow, Thermo Fisher Scientific’s new... Read more
Basel, 18 October 2019 Roche announces FDA approval of Xofluza (baloxavir marboxil) for people at high risk of developing influenza-related complications Single-dose Xofluza is the first and only antiviral medicine indicated specifically for patients at high risk of developing serious complications from influenza (flu) The Centers for Disease Control and Prevention (CDC) defines people at... Read more
AUSTIN, Texas, Oct. 1, 2019 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) announced that the company has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the ARIES® MRSA Assay. The assay is an integrated, real-time, polymerase chain reaction (PCR) based, qualitative, in vitro diagnostic test for the direct detection of methicillin-resistant Staphylococcus aureus (MRSA)... Read more
Basel, 30 September 2019 FDA approves Roche’s Rituxan (rituximab) in children with two rare blood vessel disorders Rituxan is the first and only FDA-approved treatment for paediatric patients 2 years of age and older living with granulomatosis with polyangiitis or microscopic polyangiitis These two forms of vasculitis in children are rare and associated with severe,... Read more
PERTH, Australia and BILLERICA, Mass., Sept. 20, 2019 /PRNewswire/ — Murdoch University and Bruker (Nasdaq: BRKR) today announced a strategic collaboration that will help transform the prevention and diagnosis of disease and personalised health around the world. The Murdoch-Bruker collaboration will play a key role within the Australian National Phenome Centre (ANPC)1, the international centre... Read more
Basel, 20 September 2019 FDA approves cobas Babesia, Roche’s first whole blood test for donor screening Roche is dedicated to helping save patients’ lives by delivering state-of-the-art solutions to aid in the protection of the global blood supply from infectious diseases If undetected, Babesia infection can be fatal in patients receiving blood transfusions from infected... Read more
Basel, 18 September 2019 FDA grants Breakthrough Therapy Designation for Roche’s Gazyva (obinutuzumab) in Lupus Nephritis There are currently no U.S. FDA-approved medicines for lupus nephritis The designation is based on the results of the phase II NOBILITY study that showed Gazyva, in combination with standard of care, helped more people achieve a complete renal... Read more
New LPC 500-Avio 500 ICP-OES Oils solution streamlines workflows and delivers accurate results in under 60 seconds WHAT: PerkinElmer Inc. has today announced its new LPC 500™ Liquid Particle Counter (LPC 500) platform which will couple with PerkinElmer’s existing Avio® 500 ICP-OES Oils system to join, for the first time, particle counting and sizing as well... Read more